2BBBullish & Bearish
Lantheus Holdings, Inc. (LNTH) trades on NASDAQ. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 40 out of 100.
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Lantheus Holdings, Inc.’s current 2BB score is 40 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 50 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| Headquarters | North Billerica, Massachusetts, United States |
| Founded | 1956 |
| Employees | 1.19K |
| P/E ratio | 26.92 |
| 52-week range | $47.27 – $111.86 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 1.3084 | — | $366.59M |
| 2026-08-06 | — | 1.3192 | — | $368.77M |
| 2026-05-05 | — | 1.2648 | — | $362.50M |
| 2026-02-26 | — | 1.1926 | — | $375.18M |